• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病:流行病学、病理生理学及诊断的临床进展

Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis.

作者信息

Eratne Dhamidhu, Loi Samantha M, Farrand Sarah, Kelso Wendy, Velakoulis Dennis, Looi Jeffrey Cl

机构信息

Neuropsychiatrist, Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, and; Melbourne Neuropsychiatry Centre, University of Melbourne, and; NorthWestern Mental Health, Melbourne, VIC, Australia.

Neuropsychiatrist, Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, and; Department of Psychiatry, University of Melbourne, and; NorthWestern Mental Health, Melbourne, VIC, Australia.

出版信息

Australas Psychiatry. 2018 Aug;26(4):347-357. doi: 10.1177/1039856218762308. Epub 2018 Apr 3.

DOI:10.1177/1039856218762308
PMID:29614878
Abstract

OBJECTIVES

To provide a clinical update for general psychiatrists on the assessment and diagnosis of Alzheimer's disease (AD), highlighting current issues regarding epidemiology, risk factors and pathophysiology from recent relevant research findings.

CONCLUSIONS

Psychiatrists can apply their skills and training in the diagnosis of AD, which is based upon a comprehensive assessment comprising history, investigations, and cognitive and functional assessment, guided by accepted diagnostic criteria.

摘要

目的

为普通精神科医生提供关于阿尔茨海默病(AD)评估与诊断的临床最新信息,重点介绍近期相关研究结果中有关流行病学、危险因素和病理生理学的当前问题。

结论

精神科医生可运用其在AD诊断方面的技能和培训,AD诊断基于全面评估,包括病史、检查以及认知和功能评估,并以公认的诊断标准为指导。

相似文献

1
Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis.阿尔茨海默病:流行病学、病理生理学及诊断的临床进展
Australas Psychiatry. 2018 Aug;26(4):347-357. doi: 10.1177/1039856218762308. Epub 2018 Apr 3.
2
Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.阿尔茨海默病:认知及神经精神症状的非药物和药物管理
Australas Psychiatry. 2018 Aug;26(4):358-365. doi: 10.1177/1039856218766123. Epub 2018 Apr 19.
3
Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region.阿尔茨海默病合并脑血管病:亚太地区现状。
J Intern Med. 2016 Oct;280(4):359-74. doi: 10.1111/joim.12495. Epub 2016 Mar 16.
4
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.阿尔茨海默病及相关疾病的诊断与治疗。美国老年精神病学协会、阿尔茨海默病协会及美国老年医学会的共识声明。
JAMA. 1997;278(16):1363-71.
5
Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.伴有血管成分的阿尔茨海默病患者的神经精神症状
Ann Agric Environ Med. 2014;21(2):412-5. doi: 10.5604/1232-1966.1108615.
6
Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.当地记忆诊所中生物标志物确诊的阿尔茨海默病、路易体痴呆和额颞叶痴呆患者临床症状的比较。
Psychogeriatrics. 2015 Dec;15(4):235-41. doi: 10.1111/psyg.12103. Epub 2014 Dec 23.
7
8
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].[美国国立衰老研究所和阿尔茨海默病协会关于阿尔茨海默病诊断指南的2011年新建议:临床前阶段、轻度认知障碍和痴呆症]
Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.
9
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.轻度认知障碍阶段阿尔茨海默病的患病率及预后
Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. Epub 2015 Feb 17.
10
[Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].[阿尔茨海默病和血管性痴呆早期的神经行为表现]
Psychiatr Pol. 2014 Mar-Apr;48(2):319-30.

引用本文的文献

1
7-α-O-Methylmorroniside ameliorated brain injury in 5×FAD mice by regulating the gut microbiome and NMDAR2B.7-α-O-甲基莫诺苷通过调节肠道微生物群和NMDAR2B改善5×FAD小鼠的脑损伤。
Front Pharmacol. 2025 May 30;16:1545566. doi: 10.3389/fphar.2025.1545566. eCollection 2025.
2
Unraveling the Enigma: Exploring the Periphery's Influence in Alzheimer's Pathophysiology-Cause or Consequence?解开谜团:探索外周在阿尔茨海默病病理生理学中的影响——是原因还是结果?
Eurasian J Med. 2025 Apr 4;57(1):1-8. doi: 10.5152/eurasianjmed.2025.24592.
3
Polydatin attenuates Alzheimer's disease induced by aluminum chloride in rats: evidence for its antioxidant and anti-inflammatory effects.
虎杖苷减轻氯化铝诱导的大鼠阿尔茨海默病:其抗氧化和抗炎作用的证据。
Front Pharmacol. 2025 Apr 17;16:1574323. doi: 10.3389/fphar.2025.1574323. eCollection 2025.
4
Exploring the Link Between Periodontitis and Alzheimer's Disease-Could a Nanoparticulate Vaccine Break It?探索牙周炎与阿尔茨海默病之间的联系——纳米颗粒疫苗能否打破这种联系?
Pharmaceutics. 2025 Jan 21;17(2):141. doi: 10.3390/pharmaceutics17020141.
5
Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.阿尔茨海默病(AD)中的组蛋白去乙酰化:希望还是炒作?
Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.
6
Understanding the Molecular Impact of Physical Exercise on Alzheimer's Disease.了解体育锻炼对阿尔茨海默病的分子影响。
Int J Mol Sci. 2024 Dec 18;25(24):13576. doi: 10.3390/ijms252413576.
7
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.利用脑脊液生物标志物诊断阿尔茨海默病:澳大利亚视角
Front Psychiatry. 2024 Dec 5;15:1488494. doi: 10.3389/fpsyt.2024.1488494. eCollection 2024.
8
Beyond Wolfram Syndrome 1: The Gene's Role in Alzheimer's Disease and Sleep Disorders.超越沃拉夫综合征 1:该基因在阿尔茨海默病和睡眠障碍中的作用。
Biomolecules. 2024 Oct 31;14(11):1389. doi: 10.3390/biom14111389.
9
Advancing Alzheimer's Research With Zebrafish Models: Current Insights, Addressing Challenges, and Charting Future Courses.利用斑马鱼模型推进阿尔茨海默病研究:当前见解、应对挑战及规划未来方向
Cureus. 2024 Aug 15;16(8):e66935. doi: 10.7759/cureus.66935. eCollection 2024 Aug.
10
Unveiling the therapeutic potential of extract and its depsides/depsidones in combatting A42 peptides aggregation and neurotoxicity in Alzheimer's disease.揭示提取物及其缩酚酸/缩酚酮在对抗阿尔茨海默病中Aβ42肽聚集和神经毒性方面的治疗潜力。
Front Pharmacol. 2024 Aug 13;15:1426569. doi: 10.3389/fphar.2024.1426569. eCollection 2024.